...
首页> 外文期刊>Electroanalysis >The New Application of Boron Doped Diamond Electrode Modified with Nafion and Lead Films for Simultaneous Voltammetric Determination of Dopamine and Paracetamol
【24h】

The New Application of Boron Doped Diamond Electrode Modified with Nafion and Lead Films for Simultaneous Voltammetric Determination of Dopamine and Paracetamol

机译:Nafion和铅膜修饰的硼掺杂金刚石电极在伏安法同时测定多巴胺和扑热息痛中的新应用

获取原文
获取原文并翻译 | 示例
           

摘要

A new voltammetric procedure for the simultaneous determination of dopamine (DA) and paracetamol (PA) using boron doped diamond electrode modified with Nafion and lead films (PbF/Nafion/BDDE) was investigated. The use of this electrode resolved the overlapped voltammetric waves of DA and PA into well- defined peaks with peak to peak separation of about 320 mV. Under the optimized experimental conditions in differential pulse voltammetric technique, DA and PA gave a linear response over the ranges 2.0 x 10(-7)- 1.0 x 10(-4) mol L-1*(R-2 = 0.9996) and 5.0 x 10(-) 7-1.0 x 10(-3) mol L-1 (R-2 = 0.9979), respectively. The detection limits were found to be 5.4 x 10(-)8 mol L-1 for DA and 1.4 x 10(-7) mol L-1 for PA. They are lower, comparable or in some cases a little bit higher than those obtained using other electrochemical sensors. However, the proposed procedure of the sensor preparation is much simpler than procedures described in the literature with a lower detection limit. The proposed procedure was successfully applied to the determination of PA in some commercial pharmaceuticals as well as to the simultaneous determination of DA and PA in human urine, whole blood and serum samples directly without any separation steps.
机译:研究了一种新的伏安法,该方法使用由Nafion和铅膜修饰的掺硼金刚石电极(PbF / Nafion / BDDE)同时测定多巴胺(DA)和对乙酰氨基酚(PA)。使用该电极可将DA和PA的重叠伏安波分解为定义明确的峰,峰与峰之间的间隔约为320 mV。在差分脉冲伏安技术的最佳实验条件下,DA和PA在2.0 x 10(-7)-1.0 x 10(-4)mol L-1 *(R-2 = 0.9996)和5.0的范围内给出线性响应分别为x 10(-)7-1.0 x 10(-3)mol L-1(R-2 = 0.9979)。发现检测限对于DA为5.4 x 10(-)8 mol L-1,对于PA为1.4 x 10(-7)mol L-1。它们比使用其他电化学传感器获得的值低,可比或在某些情况下更高。然而,所提出的传感器制备方法比文献中描述的方法简单得多,具有较低的检测限。所提出的方法已成功地用于某些商业药物中PA的测定,以及直接测定人尿,全血和血清样品中的DA和PA,而无需任何分离步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号